According to the researchers, the greater lifetime expectancy for ladies results in a greater lifetime threat of several diseases.. 1 in 6 women and 1 in 10 males at risk for Alzheimer’s disease in their lifetime Experts from Boston University College of Medicine possess estimated that a single in six ladies are at risk for developing Alzheimer’s disease within their lifetime, while the risk for males is one in ten. These findings were released by the Alzheimer’s Association within their publication 2008 Alzheimer’s Disease: Facts and Figures.Although these anti-EGFR antibodies do display some anti-tumor activity in patients, they are definately not ideal because they bind to EGFR on both cancer cells and regular cells. As a result, they target normal tissues as well as the tumor, and side-results, although mild, are normal. more importantly Perhaps, the ‘first era’ antibodies are limited within their clinical program and their capacity for improvement. We need to increase the therapeutic efficacy of the obtainable anti-EGFR antibodies, clarifies Dr.